USC Viterbi reports that researchers from the USC Viterbi School of Engineering and the Keck School of Medicine at USC have engineered peptide nanoparticles that outsmart the biological system and target kidney cells, an innovation that may prove critical to addressing chronic kidney disease. (August 22, 2018)

USC News wrote that researchers at USC have invented a device that could significantly improve care for people with hydrocephalus, a chronic condition that causes excessive fluid in the brain. (August 3, 2018)

USC Dornsife wrote that Peter Kuhn has initiated two new research projects on two types of cancer at the USC Michelson Center for Convergent Bioscience. For both, he aims to create the equivalent of a navigation tool for oncology teams to select the best treatment options for patients based on the genetic characteristics of their cancer and their own health profile. (July 17, 2018)

Trojan Family Magazine wrote that the convergence at Michelson Hall of scientists, doctors, institutions, families and philanthropists all dedicated to drug discovery and development are making the difference in finding solutions to the world’s most pressing health challenges. (July 16, 2018)

USC Viterbi reported that the USC Michelson Center for Convergent Bioscience has partnered with Agilent Technologies, a Silicon Valley-based public research, development, and manufacturing company, to establish the Agilent Center of Excellence in Biomolecular Characterization. (May 30, 2018)

USC Viterbi reported that Andrea Armani and her team developed a portable optical diagnostics system (PODS) prototype which can do “rapid, broad population screening for malaria in low-resource environments,” according to Armani. (May 23, 2018)

Artist and USC graduate Kella Vangsness tells USC News she imagines stem cells as “‘superheroes’ fighting against ‘villains’ of disease.” (May 21, 2018)

USC President C. L. Max Nikias won the 2018 Society for Brain Mapping & Therapeutics Humanitarian Award. Click to watch testimony from Dr. Gary K. Michelson, founder of the Michelson Medical Research Foundation, Dr. Steve Kay, USC’s Director of Convergent Biosciences, and many others including USC trustees, deans, and world-renowned researchers. (April 20, 2018)

USC Viterbi wrote that USC start-up Senseer has developed microsensing technologies to improve care for patients with hydrocephalus. (April 12, 2018)

USC News writes that researchers from the Bridge Institute at the USC Michelson Center for Convergent Bioscience have launched a massive effort to construct a detailed, virtual 3-D model of the pancreatic beta cell and its components — a global project that aims to one day curb the worldwide rise of diabetes. (March 23, 2018)